FDA approves 3rd COVID-19 vaccine jab for immunocompromised people
Category: #health  By Mateen Dalal  Date: 2021-08-13
  • share
  • Twitter
  • Facebook
  • LinkedIn

FDA approves 3rd COVID-19 vaccine jab for immunocompromised people

The U.S. FDA (Food and Drug Administration) has revised the emergency use authorizations (EUA) status of the Pfizer and Moderna Covid-19 vaccines to permit people with weakened immune systems to receive its third dose.

The move comes after a panel of CDC experts gathered in July and advised higher doses for immunocompromised adults.

Doctors believe it's becoming increasingly evident that many of these people are still vulnerable to Covid after vaccination because their immune systems may not generate a strong reaction to the doses.

According to the CDC, around 2.7% of adults in the United States are immunocompromised. It is uncertain which groups will be covered under the FDA's forthcoming action. Organ transplant recipients, cancer patients, and HIV patients are just a few examples of immunocompromised patients.

For example, organ transplant recipients are required to take medications to lower their immune systems response so that their bodies can accept new organs. Yet, after being vaccinated, most of these patients never produced antibodies to the coronavirus, claims a study. The others merely created minimal defenses.

According to that study conducted by Johns Hopkins University, the third dose of vaccination increased the immunity levels of such cases.

Notably, the emergency use authorization excludes fully vaccinated people, otherwise healthy people. Both the Pfizer and Moderna vaccines are highly successful in reducing hospitalization and death in these individuals.

The CDC advisory group is scheduled to meet Friday, where it may vote on whether to recommend the third shot for immunocompromised people officially. The panel must give its approval before doctors can start recommending larger doses.

Such a vote is held after the FDA takes regulatory action, such as the expected adjustment to the emergency use authorization.

The Mississippi Department of Health advised that immunocompromised persons take an additional vaccine shot, even though federal health officials have not yet signed on it.

Source Credit - https://www.nbcnews.com/health/health-news/fda-poised-ok-third-vaccine-dose-immune-compromised-people-n1276602

 

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Health insurer Alan acquires Jour to enter the mental health market
Health insurer Alan acquires Jour to enter the mental health market
By Mateen Dalal

Alan, a health insurance startup based in France, has acquired American digital behavioral health firm, Jour for $20 million. The acquisition has assisted the French health insurer to launch its new digital health service, Alan Mind, helping it ...

WAVE Electronics adds CYNC™ Smart Home solutions to its portfolio
WAVE Electronics adds CYNC™ Smart Home solutions to its portfolio
By Mateen Dalal

South Korean consumer equipment firm, WAVE Electronics has recently formed an alliance with home automation company, Savant Systems, Inc. to provide CYNC™ smart home solutions to its contractors, custom installation professionals, and builders ...

WardWizard Innovations & Mobility to invest $20Mn in EV business
WardWizard Innovations & Mobility to invest $20Mn in EV business
By Mateen Dalal

Indian electric vehicle manufacturer, WardWizard Innovations and Mobility have expressed plans to spend INR 150 crore (USD 20 million) in the coming six months in its EV business, as it seeks to ramp up technology and infrastructure, among other thin...